Array Market (Life Science and Biotechnology Instruments), By Type, By End User, And By Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Array Market (Life Science and Biotechnology Instruments), By Type, By End User, And By Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

A DNA microarray or chip is a semiconductor surface on which sequences of many varied genes are bonded to probes. DNA microarrays are used to genotype different areas of a genome or to assess the expression levels of several genes at once. The method is applicable to areas such as clinical diagnostics, agriculture, environmental management, and other fields. A microarray or biochip is a lab-oriented microscope slide that is usually made of glass, a silicon chip, or a nylon membrane. It is a 2D array (sometimes 3D) whose surface is provided with thousands of minute pores in defined positions.

Market Dynamics

Microarrays leverage biological information with bioinformatics knowledge to bring new insights to many biological systems and have been applied most intensively to the field of cancer research. A microarray, therefore, measures the levels of mRNA transcripts in a sample, and since thousands of gene fragments can be located on an array, it can provide a genome-wide view of gene expression in cancer. Thus, the increasing prevalence of cancer is expected to foster market growth over the forecast period. For instance, In February 2021, according to the report published by Globocan, a worldwide database of cancer incidence and mortality rates, 19.3 million new cancer cases were reported worldwide in 2020. Female breast cancer had surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases globally in 2020, followed by lung, colorectal, prostate, and stomach cancers.

Furthermore, According to the Centers for Disease Control and Prevention, there were 1,603,844 new cancer cases and 602,347 people who died of cancer in the U.S. in 2020

Key features of the study:

• This report provides an in-depth analysis of the global array market (life science and biotechnology instruments) and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global array market (life science and biotechnology instruments) based on the following parameters–Company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Illumina, Inc., Roche Diagnostics Nederland B.V., Bio-Rad Laboratories, Inc., Life Technologies, Caliper Life Sciences, Perkin Elmer, Inc., Siemens Healthineers, Agilent Technologies Inc., PathogenDx, Inc., Twist Bioscience Corporation, Arraylt Corporation, Molecular Device, LLC and Raybiotech Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global array market (life science and biotechnology instruments)report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global array market (life science and biotechnology instruments)

Detailed Segmentation:

• Global Array Market (Life Science and Biotechnology Instruments), By Type:
• DNA Array
• Protein Array
• Tissue Array
• Cell Array
• Others(Peptide Array and Others)
• Global Array Market (Life Science and Biotechnology Instruments), By End user:
• Biopharmaceutical and Pharmaceutical Companies
• Diagnostic Laboratories
• Research Laboratories
• Others (Academic Institutes and among Others)
• Global Array Market (Life Science and Biotechnology Instruments), By Region:
• NorthAmerica
• U.S.
• Canada
• LatinAmerica
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• AsiaPacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• MiddleEast
• GCC
• Israel
• Rest of Middle East
• Africa
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• Roche Diagnostics Nederland B.V.
• Bio-Rad Laboratories, Inc.
• Life Technologies
• Caliper Life Sciences
• Perkin Elmer, Inc.
• Siemens Healthineers
• Agilent Technologies Inc.
• PathogenDx, Inc.
• Twist Bioscience Corporation
• Arraylt Corporation
• Molecular Device, LLC
• Raybiotech Inc.